๐Ÿ‡ฎ๐Ÿ‡ชIreland
16ยฐC Partly Cloudy ยท Dublin
Live Updates
--:--:-- IST
Writer Login
Latest
A Global Milestone for Wellness: Chanelle McCoy Health Secures Historic Dual SFDA and European Novel Food Regulatory Approvals โ—† The Digital and Regulatory Frontier: Top 10 Technical and GMP Trends Shaping Pharma in 2026 โ—† Funding the Future: Inside the โ‚ฌ75k Women TechEU and ยฃ10M Createch Grants for Startups and SMEs โ—† FDA Fires Warning Shot at Sanofi's Irish Plant Over Data Cover-Up and Altuviiio Quality Failings โ—† Top Universities in Ireland: Discover the Country's Leading Higher Education Institutions โ—† The Irish Startup Ecosystem: A Comprehensive Funding and Development Guide for Entrepreneurs โ—† Addiction Counsellors of Ireland Launch Strategic Plan 2026โ€“2029 to Prepare for CORU Regulation โ—† Ireland Funds โ‚ฌ426,000 Behavioral App for Alcohol Reduction Amid Record Treatment Demand โ—† A Global Milestone for Wellness: Chanelle McCoy Health Secures Historic Dual SFDA and European Novel Food Regulatory Approvals โ—† The Digital and Regulatory Frontier: Top 10 Technical and GMP Trends Shaping Pharma in 2026 โ—† Funding the Future: Inside the โ‚ฌ75k Women TechEU and ยฃ10M Createch Grants for Startups and SMEs โ—† FDA Fires Warning Shot at Sanofi's Irish Plant Over Data Cover-Up and Altuviiio Quality Failings โ—† Top Universities in Ireland: Discover the Country's Leading Higher Education Institutions โ—† The Irish Startup Ecosystem: A Comprehensive Funding and Development Guide for Entrepreneurs โ—† Addiction Counsellors of Ireland Launch Strategic Plan 2026โ€“2029 to Prepare for CORU Regulation โ—† Ireland Funds โ‚ฌ426,000 Behavioral App for Alcohol Reduction Amid Record Treatment Demand โ—†
Markets ยท 15 min delay
NBI4,187.6โ–ฒ +1.14%
PFE28.42โ–ผ -0.38%
AZN74.18โ–ฒ +0.81%
NVO103.55โ–ฒ +2.07%
ROG261.40โ–ผ -0.55%
ABBV174.92โ–ฒ +0.29%
EUR/USD1.0842โ–ผ -0.12%
ISEQ9,241.3โ–ฒ +0.62%
NBI4,187.6โ–ฒ +1.14%
PFE28.42โ–ผ -0.38%
AZN74.18โ–ฒ +0.81%
NVO103.55โ–ฒ +2.07%
ROG261.40โ–ผ -0.55%
ABBV174.92โ–ฒ +0.29%
EUR/USD1.0842โ–ผ -0.12%
Updated 04 Jul 2026 ยท HPRA open data

GlaxoSmithKline Trading Services Limited โ€” Licensed Medicines

26 medicines held by GlaxoSmithKline Trading Services Limited on the Irish market, from the HPRA register of authorised products.

A B C D E F G H I J K L M N O P Q R S T U V W X Y Z 0โ€“9
โ† All medicines ยท 26 products held by GlaxoSmithKline Trading Services Limited
MedicineActive substanceLicence holderStatus
ANORO ELLIPTA 55 micrograms/22 micrograms inhalation powder, pre-dispensed
EU/1/14/898/001-003
Vilanterol trifenatate, Umeclidinium bromide GlaxoSmithKline Trading Services Limited โ€”
AVAMYS 27.5 micrograms/spray, nasal spray suspension
EU/1/07/434/001-003
Fluticasone furoate GlaxoSmithKline Trading Services Limited โ€”
BLENREP 100 mg powder for concentrate for solution for infusion
EU/1/25/1948/002
Belantamab Mafodotin GlaxoSmithKline Trading Services Limited โ€”
BLENREP 70 mg powder for concentrate for solution for infusion
EU/1/25/1948/001
Belantamab Mafodotin GlaxoSmithKline Trading Services Limited โ€”
Dectova 10 mg/mL solution for infusion
EU/1/18/1349/001
Zanamivir GlaxoSmithKline Trading Services Limited โ€”
Elebrato Ellipta 92 micrograms/55 micrograms/22 micrograms inhalation powder, pre-dispensed
EU/1/17/1237/001-003
Fluticasone furoate, Umeclidinium bromide, Vilanterol trifenatate GlaxoSmithKline Trading Services Limited โ€”
Incruse Ellipta 55 micrograms inhalation powder, pre-dispensed
EU/1/14/922/001-003
Umeclidinium bromide GlaxoSmithKline Trading Services Limited โ€”
JEMPERLI 500 mg concentrate for solution for infusion
EU/1/21/1538/001
Dostarlimab GlaxoSmithKline Trading Services Limited โ€”
LAVENTAIR ELLIPTA 55 micrograms/22 micrograms inhalation powder, pre-dispensed
EU/1/14/899/001-003
Umeclidinium bromide, Vilanterol trifenatate GlaxoSmithKline Trading Services Limited โ€”
Nucala 100 mg powder for solution for injection
EU/1/15/1043/001-002
Mepolizumab GlaxoSmithKline Trading Services Limited โ€”
Nucala 100 mg solution for injection in pre-filled pen
EU/1/15/1043/003-004
Mepolizumab GlaxoSmithKline Trading Services Limited โ€”
Nucala 100 mg solution for injection in pre-filled syringe
EU/1/15/1043/005-006
Mepolizumab GlaxoSmithKline Trading Services Limited โ€”
Nucala 40 mg solution for injection in pre-filled syringe
EU/1/15/1043/009-010
Mepolizumab GlaxoSmithKline Trading Services Limited โ€”
Omjjara 100 mg film-coated tablets
EU/1/23/1782/001
Momelotinib Dihydrochloride Monohydrate GlaxoSmithKline Trading Services Limited โ€”
Omjjara 150 mg film-coated tablets
EU/1/23/1782/002
Momelotinib Dihydrochloride Monohydrate GlaxoSmithKline Trading Services Limited โ€”
Omjjara 200 mg film-coated tablets
EU/1/23/1782/003
Momelotinib Dihydrochloride Monohydrate GlaxoSmithKline Trading Services Limited โ€”
Rolufta Ellipta 55 micrograms inhalation powder, pre-dispensed
EU/1/17/1174/001-003
Umeclidinium bromide GlaxoSmithKline Trading Services Limited โ€”
Trelegy Ellipta 92 micrograms/55 micrograms/22 micrograms inhalation powder, pre-dispensed
EU/1/17/1236/001-003
Fluticasone furoate, Umeclidinium bromide, Vilanterol GlaxoSmithKline Trading Services Limited โ€”
Volibris 10 mg film-coated tablets
EU/1/08/451/003-004
Ambrisentan GlaxoSmithKline Trading Services Limited โ€”
Volibris 2.5 mg film-coated tablet
EU/1/08/451/005
Ambrisentan GlaxoSmithKline Trading Services Limited โ€”
Volibris 5 mg film-coated tablets
EU/1/08/451/001-002
Ambrisentan GlaxoSmithKline Trading Services Limited โ€”
Zeffix 100 mg Film-coated tablet
EU/1/99/114/001
Lamivudine GlaxoSmithKline Trading Services Limited โ€”
Zeffix 100 mg Film-coated tablet
EU/1/99/114/002
Lamivudine GlaxoSmithKline Trading Services Limited โ€”
Zeffix 5 mg/ml Oral solution
EU/1/99/114/003
Lamivudine GlaxoSmithKline Trading Services Limited โ€”
Zejula 100 mg Capsule, hard
EU/1/17/1235/001-003
Niraparib tosylate monohydrate GlaxoSmithKline Trading Services Limited โ€”
Zejula 100 mg Film-coated tablet
EU/1/17/1235/004-005
Niraparid tosylate monohydrate GlaxoSmithKline Trading Services Limited โ€”

Data: Health Products Regulatory Authority (HPRA) open dataset (โ€œAuthorised or Transfer Pending Productsโ€), licensed CC BY 4.0, refreshed daily. Regulatory information only โ€” not medical advice.